𝔖 Bobbio Scriptorium

✦ LIBER ✦

High-Dose Therapy Improves Progression-Free Survival and Survival in Relapsed Follicular Non-Hodgkin's Lymphoma: Results From the Randomized European CUP Trial

✍ Scribed by Schouten, H. C.

Book ID: 126955145
Publisher: American Society of Clinical Oncology
Year: 2003
Tongue: English
Weight: 137 KB
Volume: 21
Category: Article
ISSN: 0732-183X
DOI: 10.1200/jco.2003.10.023

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The remission status before and the PCR

The remission status before and the PCR status after high-dose therapy with peripheral blood stem cell support are prognostic factors for relapse-free survival in patients with follicular non-Hodgkin’s lymphoma

✍ Moos, M; Schulz, R; Martin, S; Benner, A; Haas, R 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 135 KB

High dose therapy and autologous stem ce

High dose therapy and autologous stem cell transplant does not improve survival compared with continued combination chemotherapy in people at high risk of relapse after initial treatment of advanced Hodgkin’s lymphoma: Abstracted from: Federico M, Bellei M, Brice P et al. High-dose therapy and autologous stem-cell transplantation versus conventional therapy for patients with advanced Hodgkin’s lymphoma responding to front-line therapy. Journal of Clinical Oncology 2003; 21: 2320–2325

📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 83 KB